Medical and Hospital News  
EPIDEMICS
Zimbabwe lacks AIDS drugs to expand treatment: official

by Staff Writers
Harare (AFP) July 11, 2010
Zimbabwe may not have enough anti-AIDS drugs to comply with World Health Organisation recommendations on providing treatment to people with HIV, a top health official said Sunday.

Zimbabwe is currently treating about 200,000 people whose immune systems have been severely weakened by the disease, but the WHO recommends that treatment should start earlier.

"The number of people in need of treatment will double if we follow the World Health Organisation plan," Tsitsi Mutasa Apollo, co-ordinator of HIV treatment in the health ministry, said in the state-run Sunday Mail.

"We are likely to experience more drug shortages," said Apollo.

The new guidelines would mean about 500,000 people need treatment, the paper said.

Zimbabwe's prevention and treatment campaign relies on donor funding, after a near decade of economic crisis also which crippled health services.

The country imposes an AIDS levy on workers to fund drug procurement for over 1.6 million people living with the virus.

Last year HIV infected 13.7 percent of adults, down from a high of 33 percent in 1999.

The decline has been attributed to donor-backed prevention campaigns which promotes safe sex and discourages multiple sexual partners.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
Breakthrough antibodies neutralize most known AIDS strains
Washington (AFP) July 8, 2010
US researchers have discovered two powerful antibodies that neutralize more than 90 percent of all known strains of the HIV virus in the lab, new research released Thursday showed. NIH-led scientists discovered the antibodies known as VRCO1 and VRCO2 that prevent most HIV strains from infecting human cells. The find is a potential breakthrough for advancing HIV vaccine design, and antibody t ... read more







EPIDEMICS
Six months after quake, Haitians frustrated by aid trickle

New BP cap, ships could capture all leaking oil: US

China to begin major quake reconstruction effort

US government launches new website on Gulf oil spill

EPIDEMICS
New System Helps Locate Car Park Spaces

Skyhook Wireless Partners With Samsung Electronics For Leading Location System

Telogis Expands Reach Into Construction And Heavy Lifting Sectors

Global Number Of Traffic Information Users To Exceed 370 Million By 2015

EPIDEMICS
Timor-Leste warms to Australia asylum idea

U.S. government challenges Ariz. law

Tibetan Adaptation To Altitude Took Less Than 3,000 Years

A Butterfly Effect In The Brain

EPIDEMICS
Canada needs more, bigger parks to protect wildlife: study

Marine Scientists Return With Rare Creatures From The Deep

China to launch global search for panda keepers

The Woolly Mammoth And Saber-Toothed Cat Wipeout

EPIDEMICS
Zimbabwe lacks AIDS drugs to expand treatment: official

Breakthrough antibodies neutralize most known AIDS strains

11.5 percent HIV/AIDS prevalence in Mozambique: report

WHO probe grapples with differing views on flu pandemic

EPIDEMICS
China tells dissident writer book on PM could mean prison

Google says still waiting for China licence decision

Celebrations and sadness as Dalai Lama turns 75

Lenovo says Apple missing huge opportunities in China

EPIDEMICS
Gunmen seize 12 sailors in ship attack off Nigeria: navy

Singapore ship with Chinese crew hijacked off Somalia

Sudan says Cyprus 'arms ship' contains mining explosives

Islamists, unpaid troops hit Somali regime

EPIDEMICS
China bank lending cools in June

IMF warns of 'downside risks' in Asia

IMF raises global growth forecast despite financial shocks

G8 succeeds in accountability


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement